This is the second article about the study. This work focused on a cohort of patients defined «at risk» because of age, different comorbidities and co-therapies. 1296 patients at risk (66.3% of general sample) were identified. The most frequent risk factor was old age (over 70 years) followed by hypertension and gastrointestinal comorbidities. Patients' clinical condition at follow-up was analysed in order to identify eventually adverse reactions after Coxib assumption. The aim of the study was to promote an active collaboration with general practitioners in order to underline the importance of their role in Pharmacovigilance specifically regarding to new drugs.
|Translated title of the contribution||Post-marketing surveillance of cyclooxygenase-2 selective inhibitors: Population at risk|
|Number of pages||5|
|Journal||Giornale Italiano di Farmacia Clinica|
|Publication status||Published - Jan 2003|
ASJC Scopus subject areas
- Pharmacology (medical)